SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-14489"
 

Sökning: id:"swepub:oai:DiVA.org:liu-14489" > Plasma S/R ratio of...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002803naa a2200301 4500
001oai:DiVA.org:liu-14489
003SwePub
008070521s2007 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-144892 URI
024a https://doi.org/10.1097/MBC.0b013e3280444bfd2 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Osman, Abdimajidu Östergötlands Läns Landsting,Linköpings universitet,Klinisk kemi,Hälsouniversitetet4 aut0 (Swepub:liu)majos21
2451 0a Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
264 1c 2007
338 a print2 rdacarrier
520 a We recently reported that the low-dose VKORC1*2 haplotype is an important genetic determinant for warfarin dose requirement and is associated with difficulties to attain stable therapeutic prothrombin time-International Normalized Ratio in patients undergoing anticoagulation therapy. The aim of this study was to investigate whether patients with VKORC1*2 compared with patients carrying high-dose haplotypes VKORC1*3 or VKORC1*4 had different warfarin S/R ratios in their plasma, and whether that was related to CYP2C9 variants CYP2C9*2 and CYP2C9*3 or other factors. Samples from patients previously haplotyped for VKORC1 and measured for plasma warfarin concentration were genotyped for the CYP2C9 variants CYP2C9*2 and CYP2C9*3. Nonparametric statistical analysis was performed to elucidate whether there was any significant difference in the warfarin S/R ratio between the two patient groups. Our result shows that there is a significant difference (P < 0.01) in warfarin S/R ratios between VKORC1*2 and VKORC1*3 or VKORC1*4 patients. This difference did not originate from CYP2C9 variants CYP2C9*2 and CYP2C9*3. We speculate that VKORC1 haplotypes possibly are linked to some unidentified factors involved in the metabolic clearance of warfarin enantiomers. Dose-dependent variations in (S)-warfarin and (R)-warfarin clearance in these patients can also be a probable explanation for the difference in warfarin S/R ratios.
653 a MEDICINE
653 a MEDICIN
700a Enström, Camillau Linköpings universitet,Institutionen för biomedicin och kirurgi,Hälsouniversitetet4 aut0 (Swepub:liu)camen30
700a Lindahl, Tomasu Östergötlands Läns Landsting,Linköpings universitet,Klinisk kemi,Hälsouniversitetet4 aut0 (Swepub:liu)tomli13
710a Linköpings universitetb Klinisk kemi4 org
773t Blood Coagulation and Fibrinolysisg 18:3, s. 293-296q 18:3<293-296x 0957-5235x 1473-5733
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-14489
8564 8u https://doi.org/10.1097/MBC.0b013e3280444bfd

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Osman, Abdimajid
Enström, Camilla
Lindahl, Tomas
Artiklar i publikationen
Blood Coagulatio ...
Av lärosätet
Linköpings universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy